{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:47:16Z","timestamp":1790650036896,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.4158\/ep-2019-0221","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T13:47:23Z","timestamp":1572011243000},"page":"207-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Side Effects of PTU and MMI in the Treatment of Hyperthyroidism: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"26","author":[{"given":"Wenshu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0221_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP-2019-0221_bb0015","article-title":"Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: a meta-analysis","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"key":"10.4158\/EP-2019-0221_bb0020","first-page":"2312","article-title":"Graves' disease in the elderly [In Japanese]","volume":"64","author":"Itaka","year":"2016","journal-title":"Nihon Rinsho"},{"key":"10.4158\/EP-2019-0221_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.94.2448.518.c","article-title":"The Effect of Sulfanilylguanidine on the Thyroid of the Rat","volume":"94","author":"Mackenzie","year":"1941","journal-title":"Science"},{"key":"10.4158\/EP-2019-0221_bb0030","first-page":"3472","article-title":"Effects of methimazole and prothiouracil on patients with hyperthyroidism and liver function [in Chinese]","volume":"22","author":"Shen","year":"2016","journal-title":"Med Rev"},{"key":"10.4158\/EP-2019-0221_bb0035","first-page":"129","article-title":"Effects of methimazole and prothiouracil on liver function in patients with hyperthyroidism [in Chinese]","volume":"21","author":"Huang","year":"2015","journal-title":"Contemp Med"},{"key":"10.4158\/EP-2019-0221_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","author":"Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.4158\/EP-2019-0221_bb0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1573406411006040239","article-title":"Treatment of Graves' hyperthyroidism with thionamides-derived drugs: review","volume":"6","author":"Garc\u00eda-Mayor","year":"2010","journal-title":"Med Chem"},{"key":"10.4158\/EP-2019-0221_bb0050","first-page":"78","article-title":"Clinical effect of methimazole and prothiouracil on hyperthyroidism and its effect on liver function [in Chinese]","volume":"13","author":"Zhou","year":"2016","journal-title":"North Pharmacol"},{"key":"10.4158\/EP-2019-0221_bb0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2012.04365.x","article-title":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","volume":"77","author":"Otsuka","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2019-0221_bb0060","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease","volume":"92","author":"Nakamura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0065","first-page":"113","article-title":"Curative effect of methimazole and prothiouracil on hyperthyroidism and its effect on liver function [in Chinese]","volume":"16","author":"Liu","year":"2018","journal-title":"Chin Foreign Med Res"},{"key":"10.4158\/EP-2019-0221_bb0070","first-page":"9","article-title":"Comparison of clinical efficacy between methimazole and prothiouracil in the treatment of hyperthyroidism with Graves' disease [in Chinese]","volume":"12","author":"Zhu","year":"2017","journal-title":"Chin J Pract Med"},{"key":"10.4158\/EP-2019-0221_bb0075","first-page":"93","article-title":"Curative effect of methimazole and prothiouracil on hyperthyroidism and its effect on liver function [in Chinese]","volume":"29","author":"Lin","year":"2017","journal-title":"Strait Pharm J"},{"key":"10.4158\/EP-2019-0221_bb0080","first-page":"145","article-title":"Comparison of effects of propylthiouracil and methimazole on liver function in hyperthyroidism [in Chinese]","volume":"21","author":"Xiong","year":"2015","journal-title":"Contemp Med"},{"key":"10.4158\/EP-2019-0221_bb0085","first-page":"547","article-title":"Effects of methimazole and propylthiouracil on liver function in patients with hyperthyroidism [in Chinese]","volume":"37","author":"Wang","year":"2016","journal-title":"J Taishan Med Coll"},{"key":"10.4158\/EP-2019-0221_bb0090","first-page":"23","article-title":"Comparison of clinical efficacy of methimazole and propylthiouracil in the treatment of hyperthyroidism and its effect on liver function [in Chinese]","volume":"5","author":"Dong","year":"2018","journal-title":"J Clin Med Lit"},{"key":"10.4158\/EP-2019-0221_bb0095","first-page":"9","article-title":"Curative effect of different doses of antithyroid drugs on patients with hyperthyroidism based on the condition and the effect on liver function [in Chinese]","volume":"12","author":"Meng","year":"2017","journal-title":"Intern Mede"},{"key":"10.4158\/EP-2019-0221_bb0100","first-page":"649","article-title":"Effects of methimazole and propylthiouracil on serum hormone levels in patients with toxic diffuse goiter hyperthyroidism [in Chinese]","volume":"15","author":"Chen","year":"2018","journal-title":"Anti-infect Med"},{"key":"10.4158\/EP-2019-0221_bb0105","first-page":"5608","article-title":"Effect observation of methimazole and propylthiouracil on Graves' hyperthyroidism [in Chinese]","volume":"34","author":"Li","year":"2013","journal-title":"JiLin Med"},{"key":"10.4158\/EP-2019-0221_bb0110","first-page":"876","article-title":"\u201cChinese thyroid disease diagnosis and treatment guide\u201d compilation group. Chinese thyroid disease diagnosis and treatment guide: hyperthyroidism [in Chinese]","volume":"46","author":"Chinese Medical Association Endocrinology Branch","year":"2007","journal-title":"Chin J Intern Med"},{"key":"10.4158\/EP-2019-0221_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1297\/cpe.20.39","article-title":"A report of three girls with antithyroid drug-induced agranulocytosis: retrospective analysis of 18 cases aged 15 years or younger reported between 1995 and 2009","volume":"20","author":"Minamitani","year":"2011","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.4158\/EP-2019-0221_bb0120","first-page":"50","article-title":"Effect of methimazole and propylthiouracil on cytokines of Graves' disease [in Chinese]","volume":"8","author":"Pang","year":"2015","journal-title":"Clin Rational Drug Use"},{"key":"10.4158\/EP-2019-0221_bb0125","first-page":"2796","article-title":"Clinical effect of methimazole and propylthiouracil on Graves' hyperthyroidism [in Chinese]","volume":"28","author":"Zhu","year":"2015","journal-title":"Med Theory Pract"},{"key":"10.4158\/EP-2019-0221_bb0130","first-page":"25","article-title":"Clinical comparison of methimazole and propylthiouracil in the treatment of Graves' disease with hyperthyroidism [in Chinese]","volume":"22","author":"Lin","year":"2014","journal-title":"Chin Med Engineer"},{"key":"10.4158\/EP-2019-0221_bb0135","first-page":"1272","article-title":"Comparative observation of different anti-thyroid drug systems in the treatment of Graves' disease [in Chinese]","volume":"8","author":"Lu","year":"2013","journal-title":"Guangdong Med Sci"},{"key":"10.4158\/EP-2019-0221_bb0140","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2169\/internalmedicine.55.7281","article-title":"Successful re-administration of low-dose of methimazole (MMI) in Graves disease patients who experienced allergic cutaneous reactions to MMI at initial treatment and had received long-term propylthiouracil (PTU)","volume":"55","author":"Kubota","year":"2016","journal-title":"Intern Med"},{"key":"10.4158\/EP-2019-0221_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2009-132041","article-title":"Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use","volume":"2009","author":"Rivkees","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.4158\/EP-2019-0221_bb0150","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1515\/jpem-2013-0288","article-title":"Clinical features at diagnosis and responses to antithyroid drug in younger children with Graves' disease compared with adolescent patients","volume":"27","author":"Sato","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1297\/cpe.26.29","article-title":"Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016","volume":"26","author":"Minamitani","year":"2017","journal-title":"Clin Pediatr Endocrinol"},{"issue":"suppl 1","key":"10.4158\/EP-2019-0221_bb0160","article-title":"Adverse events related with propylthiouracil therapy of Graves' disease in children at Cipto Mangunkusumo Hospital Jakarta","author":"Andriana","year":"2013","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.4158\/EP-2019-0221_bb0165","first-page":"637","article-title":"Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling","volume":"103","author":"Kourime","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.4158\/EP-2019-0221_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/thy.2012.0612","article-title":"Antithyroid drug treatment for Graves' disease in children: a long-term retrospective study at a single institution","volume":"24","author":"Ohye","year":"2014","journal-title":"Thyroid"},{"key":"10.4158\/EP-2019-0221_bb0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1515\/jpem.2011.194","article-title":"Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome","volume":"24","author":"Sato","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0180","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman","year":"2012","journal-title":"QJM"},{"key":"10.4158\/EP-2019-0221_bb0185","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","article-title":"Carbimazole embryopathy: an emerging phenotype","volume":"132A","author":"Foulds","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.4158\/EP-2019-0221_bb0190","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"SAFE-Med Study Group","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0195","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M17-1398","article-title":"Antithyroid drugs and congenital malformations: a nationwide Korean cohort study","volume":"168","author":"Seo","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2019-0221_bb0200","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-17-0314","article-title":"Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study","volume":"177","author":"Andersen","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2019-0221_bb0210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ando.2016.03.003","article-title":"Management of Graves' disease during pregnancy in the Poitou-Charentes region","volume":"77","author":"Hawken","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.4158\/EP-2019-0221_bb0215","first-page":"511","article-title":"Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants [In Chinese]","volume":"40","author":"Lian","year":"2005","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.4158\/EP-2019-0221_bb0220","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0225","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study","volume":"118","author":"Chen","year":"2011","journal-title":"BJOG"},{"key":"10.4158\/EP-2019-0221_bb0230","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1515\/JPEM.2003.16.9.1239","article-title":"Intellectual development and thyroid function in children who were breastfed by thyrotoxic mothers taking methimazole","volume":"16","author":"Azizi","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.4158\/EP-2019-0221_bb0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.4158\/EP-2019-0221_bb0240","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM192402141900703","article-title":"Hyperthyroidism masked as heart disease","volume":"190","author":"Levine","year":"1924","journal-title":"Boston Med Surg J"},{"key":"10.4158\/EP-2019-0221_bb0245","first-page":"19","article-title":"Hyperthyroidism in the elderly [in Italian]","volume":"76","author":"Simi","year":"2005","journal-title":"Ann Ital Chir"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20351016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20351016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:08:16Z","timestamp":1761516496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20351016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1530891X20351016"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0221","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side Effects of PTU and MMI in the Treatment of Hyperthyroidism: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}